<DOC>
	<DOCNO>NCT01549106</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability , pharmacokinetics pharmacodynamics IPI-145 single repeat oral administration , evaluate effect food ketoconazole plasma pharmacokinetics IPI-145 .</brief_summary>
	<brief_title>IPI-145 Single Ascending , Multiple Ascending , Food Effect Drug-Drug-Interaction Study</brief_title>
	<detailed_description />
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>1 . Gender : male female 2 . Age : 1855 year , inclusive 3 . Body Mass Index ( BMI ) : 18.030.0 kg/m2 4 . Medical history without major pathology 5 . For male : Willingness use adequate contraception time dose donate sperm 3 month followup visit 6 . Females negative pregnancy test screen admission , nonchildbearing potential . Females nonchildbearing potential defined woman surgically sterile postmenopausal ( define least 1 year post cessation menses follicular stimulate hormone ( FSH ) &gt; 23.0 mIU/mL ) 7 . Willing able sign write Informed Consent Form ( ICF ) 1 . Previous participation current study 2 . Evidence clinically relevant pathology 3 . History relevant drug and/or food allergy 4 . Part 4 : Known suspected adverse reaction contraindication imidazole class drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>